Trademark: 85736811
Word
QUANTIFIED LIFE
Status
Dead
Status Code
606
Status Date
Monday, July 16, 2018
Serial Number
85736811
Mark Type
4000
Filing Date
Monday, September 24, 2012
Published for Opposition
Tuesday, April 19, 2016
Abandoned Date
Monday, July 16, 2018

Trademark Owner History
Theranos, Inc. - Owner At Publication

Classifications
1 Reagents for scientific or research use; diagnostic reagents for laboratory use, namely, for clinical or medical or forensic laboratory use; chemical preparations for scientific purposes; reagents for chemical analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; testing kits containing reagents used in analyzing and detecting certain toxins for clinical or medical laboratory use; genetic identity tests comprised of reagents; antibodies for in vitro scientific or research use; biochemicals, namely, for in vitro and in vivo scientific use; biomedical compounds, namely, substrates used in analyzing and detecting certain toxins for laboratory or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use, namely, for clinical or medical or forensic laboratory use; chemically-treated nonmedical test strips for laboratory analysis of blood
5 Biological and chemical preparations for medical or veterinary use to detect and analyze diseases or physical conditions; reagents and media for medical or veterinary diagnostic purposes; clinical medical reagents; diagnostic biological and chemical preparations, namely, monoclonal antibodies for clinical, medical or veterinary use to detect and analyze substances; diagnostic kits comprised of medical diagnostic reagents and assays for medical or veterinary use for testing blood and other body fluids; diagnostic preparations for medical or veterinary purposes; drug testing kits comprised of medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic test kits comprised of reagents and assays for testing of body fluids; medical diagnostic and monitoring test strips for use in the detection of a wide variety of diseases and health conditions; test strips for medical analysis of blood; ovulation test kits; biological tissue cultures for medical or veterinary purposes; culture media for cultivating blood cells
9 Computer software for healthcare monitoring; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for use in biomonitoring of humans and of animals; computer software for medical monitoring and analysis of medical data; computer software for controlling the operation of medical test equipment and test results; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; electronic publications, namely, downloadable newsletters, blogs, e-zines, magazines, books, manuals, pamphlets, diaries and journals in the fields of healthcare, medicine, personal health and fitness, biomonitoring, medical diagnostics, monitoring and testing
10 Medical devices, namely, portable biomonitoring devices for monitoring blood pressure, pulse, heart rate, respiration, blood oxygen, blood glucose, blood composition, cholesterol, temperature and weight; medical devices, namely, apparatus for laboratory analysis of body fluids and tissue; medical devices, namely, point of care and handheld devices for analysis of drugs, proteins and other substances, and wireless transfer of medical data; medical measuring apparatus, namely, equipment for medical monitoring and analysis of body fluids and tissue; medical measuring apparatus, namely, cartridges containing sensors for measuring and analyzing bodily fluids and pharmaceutical concentrations for use with therapies or equipment for medical monitoring and analysis of substances; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for urine analysis; general diagnostic and monitoring apparatus for biological tissue or fluid analysis; apparatus for clinical diagnosis; capillary reagent tubes; capillary tubes for blood; capillary tubes for samples; containers especially made for processing blood samples; containers for medical waste; devices for monitoring blood sugar; electronic diagnostic apparatus, namely, analytic apparatus for the detection of a wide variety of diseases; health monitoring devices, namely, personal medical monitors of blood pressure, pulse, and blood oxygen, blood glucose, blood composition, cholesterol and temperature for monitoring a wide variety of physical conditions and diseases; medical diagnostic apparatus, namely, blood pressure, pulse, and blood oxygen, blood glucose, blood composition, cholesterol and temperature monitors for diagnosing a wide variety of physical conditions and diseases; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; medical monitors for monitoring a wide variety of physical conditions and diseases, namely, individualized, electronic monitors for measuring biochemical, hematological, neurological, pulmonary, muscular and cardiac activity; home or portable monitors for monitoring a wide variety of physical conditions and diseases, namely, individualized, electronic monitors for measuring biochemical, hematological, neurological, pulmonary, muscular and cardiac activity; mobile electronic devices, namely, testing, monitoring and reporting devices for medical and healthcare purposes for individualized medicine and healthcare
35 Administering pharmacy reimbursement programs and services; Administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; medical referrals; physician referrals; medical billing support services; providing an internet-based database of patient medical information designed to facilitate sharing and maintenance of patient medical information between and amongst the patient, insurers and healthcare professionals providing services to the patient
36 Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services; insurance services, namely, eligibility review and verification provided via an internet-based system for confirming patient identity, eligibility and authorization for health insurance or medicare/medicaid services
39 Biomedical services, namely, electronic storage of medical data; biomedical services, namely, the storage of human cells for medical use; consulting services in the field of air medical operations in the nature of air medical transport; medical transport services; transportation of medical waste and special waste
42 Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical laboratories; medical laboratory services; providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing a web site featuring technology that enables patients, physicians, insurers and other healthcare providers to generate, manage and exchange medical information
44 Medical evaluation services; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical diagnostic monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services, namely, conducting medical physical evaluations for detection of a wide variety of diseases and physical conditions; health care; maintaining patient medical records and files; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of a wide variety of diseases and physical conditions; providing information in the field of pet health; pet hospital services; providing a web site featuring medical information; providing a website featuring health and healthcare information; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary specialty services, namely, medical, diagnostic and health care management services and emergency and trauma services for animals

Trademark Events
Jul 16, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jul 16, 2018
Abandonment - No Use Statement Filed
Nov 22, 2017
Notice Of Approval Of Extension Request E-Mailed
Nov 20, 2017
Extension 3 Granted
Nov 20, 2017
Extension 3 Filed
Nov 20, 2017
Teas Extension Received
Jun 2, 2017
Notice Of Approval Of Extension Request E-Mailed
May 31, 2017
Extension 2 Granted
May 31, 2017
Extension 2 Filed
May 31, 2017
Teas Extension Received
Nov 22, 2016
Notice Of Approval Of Extension Request E-Mailed
Nov 18, 2016
Extension 1 Granted
Nov 18, 2016
Extension 1 Filed
Nov 18, 2016
Teas Extension Received
Jun 14, 2016
Noa E-Mailed - Sou Required From Applicant
Apr 19, 2016
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2016
Published For Opposition
Mar 30, 2016
Notification Of Notice Of Publication E-Mailed
Mar 16, 2016
Law Office Publication Review Completed
Mar 15, 2016
Exparte Appeal Terminated
Mar 15, 2016
Approved For Pub - Principal Register
Feb 25, 2016
Teas/Email Correspondence Entered
Feb 24, 2016
Correspondence Received In Law Office
Feb 24, 2016
Teas Response To Office Action Received
Nov 20, 2015
Notification Of Non-Final Action E-Mailed
Nov 20, 2015
Non-Final Action E-Mailed
Nov 20, 2015
Non-Final Action Written
Nov 3, 2015
Teas/Email Correspondence Entered
Nov 3, 2015
Correspondence Received In Law Office
Oct 27, 2015
Teas Response To Suspension Inquiry Received
May 8, 2015
Notification Of Letter Of Suspension E-Mailed
May 8, 2015
Letter Of Suspension E-Mailed
May 8, 2015
Suspension Letter Written
Apr 23, 2015
Teas/Email Correspondence Entered
Apr 23, 2015
Correspondence Received In Law Office
Apr 20, 2015
Teas Request For Reconsideration Received
Apr 20, 2015
Ex Parte Appeal-Instituted
Apr 20, 2015
Jurisdiction Restored To Examining Attorney
Apr 20, 2015
Exparte Appeal Received At Ttab
Jan 6, 2015
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 6, 2015
Teas Change Of Owner Address Received
Oct 20, 2014
Notification Of Final Refusal Emailed
Oct 20, 2014
Final Refusal E-Mailed
Oct 20, 2014
Final Refusal Written
Sep 30, 2014
Teas/Email Correspondence Entered
Sep 29, 2014
Correspondence Received In Law Office
Sep 29, 2014
Teas Response To Office Action Received
Mar 27, 2014
Notification Of Non-Final Action E-Mailed
Mar 27, 2014
Non-Final Action E-Mailed
Mar 27, 2014
Non-Final Action Written
Mar 7, 2014
Lie Checked Susp - To Atty For Action
Mar 3, 2014
Assigned To Lie
Aug 16, 2013
Notification Of Letter Of Suspension E-Mailed
Aug 16, 2013
Letter Of Suspension E-Mailed
Aug 16, 2013
Suspension Letter Written
Jul 30, 2013
Teas/Email Correspondence Entered
Jul 29, 2013
Correspondence Received In Law Office
Jul 29, 2013
Teas Response To Office Action Received
Mar 26, 2013
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 26, 2013
Teas Change Of Owner Address Received
Jan 28, 2013
Notification Of Non-Final Action E-Mailed
Jan 28, 2013
Non-Final Action E-Mailed
Jan 28, 2013
Non-Final Action Written
Jan 22, 2013
Assigned To Examiner
Sep 27, 2012
New Application Office Supplied Data Entered In Tram
Sep 27, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24